课题基金 / 基金详情

Molecular Mechanisms of iNOS Degradation

Molecular Mechanisms of iNOS Degradation
iNOS 降解的分子机制
批准号:
7061629
负责人:
N. Tony Eissa
金额:
$10.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2008-04-30

项目摘要

项目成果

N. Tony Eissa的其他基金

相似基金

相关文献

中文摘要
翻译
应聘者描述(由申请人提供):应聘者是一名最近独立的内科科学家,对生物医学研究表现出坚定的承诺。他的长期职业目标是开发一项关于呼吸道炎症分子机制的强有力的研究计划。他目前的研究目标是了解诱导型一氧化氮合酶(INOS)在呼吸道细胞中调节NO合成的分子机制,并设计出控制它的方法。如果R01申请成功,应聘者就可以继续目前的学习,启动新的项目,获得新的技能,建立新的合作关系。K02奖是为了减少候选人目前任命的临床部分,从而允许一段时间的密集研究重点,以促进他的科学发展,并扩大他做出重大研究贡献的潜力。应聘者处于一个高度支持的环境中,有优秀的导师和无数的智力发展机会。他是一个新成立的“炎症生物学”中心的教员。候选人的实验室位于中心及其核心实验室内,这两个实验室占地20,000平方英尺。新装修的最先进的开放式实验室设计设施。该中心的研究环境提供了一个动态的研究人员临界质量,为候选人的研究提供了一个协同环境。核心研究项目(R01资助的5年期8/1/02)的总体目标是了解呼吸道上皮细胞中iNOS降解的机制。它包括四个特定的目标:1)鉴定人iNOS降解途径。2)表征泛素化在iNOS降解中的可能作用。3)阐明人诱导型一氧化氮合酶的亚细胞定位。4)分析变构抑制剂对iNOS降解的调控作用。候选人正在通过合作研究解决另外三个具体目标:i)确定iNOS泛素化的特定位置。Ii)阐明磷酸化在iNOS泛素化中的作用。Iii)鉴定负责iNOS泛素化的特定泛素连接酶(E3)。研究将在上皮细胞系和原代呼吸道支气管上皮细胞中进行。建议研究的理由是,一旦了解了iNOS的降解机制,就可以设计治疗策略来改变这些途径并调节iNOS的降解。这些研究结果将加深我们对iNOS调节的细胞过程的了解,从而为未来旨在控制哮喘等呼吸道炎症疾病中NO合成的研究奠定基础。
英文摘要
DESCRIPTION (provided by applicant): The candidate is a recently independent physician-scientist who has shown strong commitment to biomedical research. His long-term career goal is to develop a strong research program in molecular mechanisms of airway inflammation. His immediate research goals are to understand the molecular mechanisms of regulation NO synthesis by inducible nitric oxide synthase (iNOS) in airway cells and devise methods to control it. A successful R01 application has the candidate poised to continue his current studies, initiate new programs, acquire new skills and build new collaborations. The K02 award is needed to reduce the clinical component of the candidate's current appointment, thus allowing a period of intensive research focus to foster his scientific development and expand his potential to make significant research contributions. The candidate is in a highly supportive environment with excellent mentors and numerous opportunities for intellectual development. He is a faculty member of a newly established center for "Biology of Inflammation". The candidate's laboratory is within the center and its core laboratories, which comprise 20,000 sq, ft. of newly renovated state-of-the-art-open lab design facilities. The center's research environment offers a dynamic critical mass of investigators providing a synergistic environment for the candidate's research. The overall objective of the core research project (a five-year R01 funded 8/1/02) is to understand the mechanisms of iNOS degradation in airway epithelial cells. It consists of four specific aims: 1) Identification of human iNOS degradation pathway. 2) Characterization of possible role of ubiquitination in iNOS degradation. 3) Elucidation of the subcellular localization of human iNOS. 4) Analysis of modulation of iNOS degradation by allosteric inhibitors. The candidate is addressing three additional specific aims through collaborative studies: I) Determination of specific sites of iNOS ubiquitination. II) Elucidation of Role of phosphorylation in iNOS ubiquitination. III) Identification of specific ubiquitin ligase (E3) responsible for iNOS ubiquitination. Studies will be conducted in epithelial cell lines and in primary airway bronchial epithelial cells. The rational for the proposed studies is that once the degradation mechanisms of iNOS are understood, therapeutic strategies can be designed to alter these pathways and modulate iNOS degradation. The results of these studies will increase our understanding of the cellular process of iNOS regulation and thus lay the groundwork for future studies aiming at controlling NO synthesis in diseases of airway inflammation such as asthma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic Strategy for LAM (Lymphangioleiomyomatosis)
  • 批准号:
    8768835
  • 项目类别:
  • 资助金额:
    $153.78万
  • 财政年份:
    2013
  • 负责人:
    N. Tony Eissa
  • 依托单位:
Therapeutic Strategy for LAM (Lymphangioleiomyomatosis)
  • 批准号:
    8599141
  • 项目类别:
  • 资助金额:
    $127.46万
  • 财政年份:
    2013
  • 负责人:
    N. Tony Eissa
  • 依托单位:
CYSTIC FIBROSIS MUTANT
  • 批准号:
    8361139
  • 项目类别:
  • 资助金额:
    $1.23万
  • 财政年份:
    2011
  • 负责人:
    N. Tony Eissa
  • 依托单位:
Cellular Regulation of Nitric Oxide in Airway Inflammation
  • 批准号:
    7824705
  • 项目类别:
  • 资助金额:
    $1.78万
  • 财政年份:
    2009
  • 负责人:
    N. Tony Eissa
  • 依托单位:
国内基金
海外基金
大鱼际掌纹特应征与5个哮喘易感基因单核苷酸多态性的关联分析
  • 批准号:
    30873315
  • 项目类别:
    面上项目
  • 资助金额:
    31.0万元
  • 批准年份:
    2008
  • 负责人:
    周兆山
  • 依托单位:
调节性T细胞和共刺激分子在过敏原早期暴露诱导哮喘免疫耐受中的作用机制研究
  • 批准号:
    30740048
  • 项目类别:
    专项基金项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2007
  • 负责人:
    李海潮
  • 依托单位:
CBP介导STAT4/STAT6相互拮抗在哮喘Th失衡中的机制
  • 批准号:
    30672268
  • 项目类别:
    面上项目
  • 资助金额:
    28.0万元
  • 批准年份:
    2006
  • 负责人:
    符州
  • 依托单位: